New human transforming genes detected by a tumorigenicity assay by Fasano,  O. et al.
  
1984, 4(9):1695. DOI: 10.1128/MCB.4.9.1695. Mol. Cell. Biol. 
O Fasano, D Birnbaum, L Edlund, J Fogh and M Wigler
 
tumorigenicity assay.
New human transforming genes detected by a
http://mcb.asm.org/content/4/9/1695
Updated information and services can be found at: 
These include:
CONTENT ALERTS
 more»cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new articles
http://mcb.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 April 13, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
MOLECULAR AND CELLULAR BIOLOGY, Sept. 1984, p. 1695-1705 Vol. 4, No. 9
0270-7306/84/091695-11$02.00/0
Copyright © 1984, American Society for Microbiology
New Human Transforming Genes Detected by a Tumorigenicity
Assay
OTTAVIO FASANO,1 DANIEL BIRNBAUM,1 LOUISE EDLUND,' JORGEN FOGH,2 AND MICHAEL WIGLERl*
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724,1 and Sloan Kettering Institute, Rye, New York
105802
Received 20 April 1984/Accepted 1 June 1984
We have developed a sensitive bioassay for transforming genes based on the tumorigenicity of cotransfected
NIH3T3 cells in nude mice. The assay differs substantially from the NIH3T3 focus assay. Using it, we have
detected the transfer of three transforming genes from the DNA of MCF-7, a human mammary carcinoma cell
line. One of these is N-ras, which is amplified in MCF-7 DNA. The other two, which we have called mcf2 and
mcf3, do not appear to be related to known oncogenes. We cannot detect their transfer by using the NIH3T3
focus assay. We do not yet know whether either mcf2 or mcf3 is associated with genetic abnormalities in MCF-7
cells.
The transfer of genomic DNA into NIH3T3 cells has led to
the discovery that genes present in some tumor cells are
capable of inducing foci of morphologically transformed
NIH3T3 cells (24, 27, 31, 33, 40). Most of the transforming
genes which have been detected this way have now been
identified as members of the ras gene family, either H-, K-,
or N-ras (8, 17, 29, 33, 36, 43). The transforming ras genes
detected by the NIH3T3 focus assay have structural gene
mutations that account for their transforming activity (34,
48, 50, 51, 55). Since the great majority of tumor DNAs
tested fail to induce transformed foci (24, 31, 33), we have
speculated that the focus assay has a bias for ras genes
containing structural mutations. Therefore, we have begun a
series of experiments to explore alternative assays for trans-
forming genes present in NIH3T3 cells after DNA transfer.
We describe here some preliminary results with an assay
system that detects new oncogenes. The system is a modifi-
cation of the one described by Blair and co-workers (2). Like
theirs, our assay also relies on the ability of transformed
NIH3T3 cells to form tumors in nude mice, but incorporates
methods of cotransfection (54) to heighten sensitivity. Using
this assay, we have transferred three human transforming
genes from the DNA of MCF-7, a human breast carcinoma
cell line. One of these is N-ras. The other two appear to be
unrelated to previously known transforming genes. The N-
ras gene is amplified in MCF-7 cells but does not appear to
contain structural mutations. We have not yet established
whether the other two genes, which we have called mcf2 and
mcf3, are associated with any genetic abnormality in MCF-
7.
MATERIALS AND METHODS
Preparation and source of DNA. High-molecular-weight
DNA from various cell lines was prepared as described
previously (31). MCF-7 was from the Human Tumor Cell
Line Bank of the Sloan Kettering Institute, Rye, N.Y. (44).
Preparation ofDNA from solid tumors was done as follows.
Tumors (1 to 2 g offrozen tissue) were finely ground by using
a pestle in a mortar containing liquid N2. The resulting
powder was added to 40 ml of 400 mM NaCl-10 mM EDTA-
20 mM Tris-hydrochloride (pH 7.5)-0.5% sodium dodecyl
sulfate prewarmed at 68°C and incubated at this temperature
* Corresponding author.
for 20 min. An additional incubation at 37°C in the presence
of proteinase K at the final concentration of 200 ,ug/ml was
carried out with very slow agitation for 24 to 48 h. Phenol
extraction and subsequent steps were as described previous-
ly (31). Plasmid and phage DNAs were prepared by pub-
lished methods (21, 49). Many plasmids that were used in
this study were generously provided by the following scien-
tists: pKOneo, D. Hanahan; psrc-11, G. Cooper; pBR-Y73,
N. Kitamura; pAB-sub3, S. Goff; pGA-FeSV, C. Sherr;
pRCII-1B, H. Hanafusa; pBR-UR2, H. Hanafusa; pAE-
PvuII, M. Bishop; pHB-11, E. Scolnick; pKBE-2, E. Scol-
nick; pm-1, D. Blair; pMCV38, M. Bishop; pVM-2, M.
Bishop; pFBJ-2, I. Verma; pSSV-11, S. Aaronson; pREV-
T3, H. Temin; pvski-1, E. Stavnezer; pMT-2.5, H. Varmus;
pSM-FeSV, C. Sherr; and blur 8, C. Schmid. Phage X
myc4.1.1 was from M. Cole.
DNA transfections and nude mice assay. All DNA transfers
used a modified calcium phosphate precipitation method (15,
54) with NIH3T3 cells as recipients (19, 31). Focus assays
were performed as previously described (31). For the nude
mouse experiments, 30 ,ug of cellular DNA plus 300 ng of
pKOneo plasmid, constructed by D. Hanahan (unpublished
data), were added as a calcium phosphate precipitate (vol-
ume, 1 ml) to each 100-mm culture dish containing 5 x 105
cells in 10 ml of Dulbecco medium and 10% calf serum (D10).
After incubation for 8 h, the precipitate was removed and
replaced by 10 ml of fresh D10. After an additional 6 h, the
cells in each plate were trypsinized and seeded into four 100-
mm dishes containing D10 plus 0.4 g of the antibiotic G418
(GIBCO Laboratories) per liter (as calculated for 100%
active antibiotic). This time schedule is critical, since the
antibiotic efficiently selects cells expressing the resistance
marker only when seeding is done at low cell density.
Refeeding of the cultures was done at intervals of 3 days,
using the same medium. The plates, each containing about
300 colonies, reached confluency after 16 to 18 days. At this
time, the four plates of cells were trypsinized, pooled,
centrifuged at 700 rpm for 5 min, and resuspended in 0.25 ml
of D10. Approximately 107 cells were injected subcutaneous-
ly over the right shoulders of athymic, 4- to 8-week-old male
or female Nu-Nu mice of Rex-Trembler origin which had
been back-crossed to Swiss three times. One deviation from
this protocol is described in the footnote to Table 1.
Tumor growth was monitored weekly, and the mean
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diameter was calculated as the cubic root of the product of
its three major diameters. Before death from tumor growth,
the mice were sacrificed, and the tumor tissue (1 to 3 g) was
frozen in liquid N2 to obtain DNA at a later time.
Southern filter-blot hybridization. DNA samples were di-
gested with restriction endonucleases and subjected to ag-
arose gel electrophoresis and filter-blot transfer by the
method of Southern (45). Filter-blot DNAs were hybridized
with nick-translated probes (26) under stringent conditions
described previously (43). Nonstringent hybridization condi-
tions entailed use of essentially the same components at 60°C
instead of 74°C. When total human or mouse DNA was nick
translated and used as a probe, its concentration during
hybridization was 0.03 ptg/ml. For hybridization with ras
probes, we nick translated these DNAs: plasmid p6aI, a
partial cDNA clone of the human N-ras gene (50); the 3.0-
kilobase-pair (kbp) EcoRI fragment containing coding exon
II of the human K-ras gene (41); and the 0.7-kbp NarI-AvaI
fragment from plasmid RS6 (11), a cDNA clone of the human
H-ras gene containing most of the coding sequences.
Isolation of mcfl, mcf2, and mcf3. Genomic libraries of
MCF-7 DNA and the secondary tumor DNAs (MCF-7-1-1,
MCF-7-2-2, and MCF-7-3-4) were constructed in X charon 4a
(4, 18) from DNA partially digested with EcoRI and fraction-
ated over a sucrose gradient as described previously (31). To
obtain clones of the mcf genes, we screened 5 x 105 phages
from libraries of secondary tumor DNAs for human se-
quences by the method of Benton and Davis (1) using nick-
translated human placental DNA as a probe (16). To obtain
mcf clones from MCF-7 DNA, we screened that library with
repeat-free fragments of the respective genes. The filter
hybridization was performed in 6x SSC-lx Denhardt (lx
SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 68°C for
20 h followed by five washings in 2x SCC at 68°C.
RESULTS
Assays with MCF-7 DNA. In brief, the new assay is
performed as follows. NIH3T3 cells are cotransfected with
cellular DNA and DNA of the pKOneo plasmid, which
renders animal cells resistant to the antibiotic G418 (46). In
each experimental group, about 103 G418-resistant colonies
containing about 104 cells are present after 2 to 3 weeks.
These are pooled and injected into one nude mouse. The
time of the first appearance of tumors and their subsequent
growth is noted. As a positive control, one set of mice is
inoculated with NIH3T3 cells exposed to genomic DNA
from al-1, an NIH3T3 transformant containing a high copy
number of the transforming human H-ras gene of T24
bladder carcinoma cells (14, 31). As a negative control, one
set of mice is inoculated with cells exposed to genomic DNA
from NIH3T3 cells. Mice are maintained for up to 3 months.
Our first experiments with the tumorigenicity assay were
performed with DNA from a human breast carcinoma cell
line, MCF-7. Lane et al. had previously reported MCF-7
DNA to be positive in the NIH3T3 focus assay (25). Howev-
er, we had consistently failed to observe any induced foci
when using this DNA as donor. Nevertheless, we did obtain
positive results using MCF-7 DNA in the nude mouse assay
(Tables 1 and 2). In two experiments, three independent
tumors were obtained. There was a low tumor incidence in
the negative control group (see tables) as well as in mice
injected with NIH3T3 cells exposed to human placental
DNA (data not shown). There is, therefore, a background of
tumor induction when testing normal DNA, a point to which
we will return later. With MCF-7 DNA, as with many other
tumor DNAs we have since examined, tumor incidence was
higher than with control DNAs, but this may not be statisti-
cally significant. We therefore do not assume that the
positive results with MCF-7 DNA reflect a genetic abnor-
mality in MCF-7 cells. The assay is, however, clearly
responsive to high copies of strongly transforming genes
since tumor incidence is markedly increased with the posi-
tive control groups, consisting of nude mice injected with
NIH3T3 exposed to DNA from al-1.
We call tumors resulting from cells exposed to MCF-7
DNA primary tumors MCF-7-1, MCF-7-2, and MCF-7-3.
DNAs prepared from the primary tumors were used again in
the tumorigenicity assay to obtain secondary tumors. The
lineages of the relevant tumors are given in Table 3. In each
case, DNA from the primary tumor was significantly more
TABLE 1. Tumorigenicity assay of MCF-7 DNAa
Donor Mean tumor diam (mm) on day: Tumor
DNA Group 14 21 28 35 42 49 56 63 designation
NIH3T3 A 0 0 0 0 Tr 14.5 17.0 20.0
0 0 0 0 Tr 6.8 3.4 0
0 0 0 0 Tr 6.6 0 0
MCF-7 B 0 9.1 18.8 23.3 MCF-7-la
0 Tr 14.6 22.3 MCF-7-lb
0 Tr 12.2 21.5 MCF-7-lc
0 Tr 8.4 9.2 18.4 MCF-7-ld
0 Tr 13.6 18.3 MCF-7-le
0 Tr 9.0 16.7 MCF-7-lf
0 Tr 6.6 13.6 MCF-7-lg
al-1 C 21.9
20.2
15.1
a Tumorigenesis assays were performed essentially as described in the text. NIH3T3 cells were exposed to both pKOneo and DNA from the indicated cell line
and then selected for G418 resistance. Two weeks later, surviving colonies were trypsinized, pooled, and injected into animals. Each group represents a pool of
G418-resistant cells. Each line represents a single nude mouse injected with ca. 5 x 106 cells from the equivalent of four plates. al-1 is an NIH3T3 transformant
with a high copy number of a transforming H-ras gene (14, 31). MCF-7 is a human breast cancer cell line (44). Tumors designated MCF-7-la through MCF-7-lg all
derived from the same initial transformed NIH3T3 cell since they display identical Southern blot patterns when probed from human repeat sequences (data not
shown). This is consistent with their origin from a single pool of transformants. These tumors are referred to collectively as MCF-7-1. In subsequent experiments,
we avoided this problem by injecting each mouse with an independent pool of transformed cells. See text for more details.
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DETECTION OF HUMAN ONCOGENES 1697
TABLE 2. Tumorigenicity assay of MCF-7 and primary tumor DNASa
Donor Mean tumor diam (mm) on day: Tumor
DNA Group 13 20 27 34 41 48 55 61 designation
NIH3T3 Al 0 0 0 0 0 0 0 0
A2 0 0 0 0 0 0 0 0
A3 0 0 0 0 0 0 0 0
A4 0 0 0 0 0 0 0 0
A5 0 0 0 0 0 0 0 0
A6 0 0 0 0 0 0 0 0
A7 0 0 0 0 0 0 0 0
MCF-7 B1 0 0 0 0 0 0 0 0
B32 0 0 0 0 0 0 0 0
B3 0 0 Tr 9.7 12.1 15.4 MCF-7-2
B4 0 0 0 0 0 0 0 0
B5 0 0 0 0 0 0 0 0
B6 0 0 0 0 0 0 0 0
B7 0 0 0 Tr 14.7 22.4 MCF-7-3
MCF-7-1 Cl 0 0 0 Tr 6.3 10.6 18.6 MCF-7-1-2
C2 0 0 0 0 0 Tr 6.6 12.1 MCF-7-1-7
C3 0 0 0 0 Tr 8.1 15.4 MCF-7-1-3
C4 0 0 0 5.1 11.0 17.2 MCF-7-1-1
C5 0 0 0 0 0 5.8 10.4 9.6 MCF-7-1-5
C6 0 0 0 0 Tr 7.9 16.5 MCF-741-4
C7 0 0 0 0 0 4.5 7.4 12.5 MCF-7-1-6
al-1 Dl 14.4 22.8
D2 10.2 20.8
D3 13.1 25.9
a See Table 1, footnote a, and the text. Each group represents an independent pool of transformants and each line a nude mouse inoculated with ca. 107 cells.
active at inducing tumorigenic NIH3T3 than the original
MCF-7 DNA itself (see, for example, Table 2). This proba-
bly results from the amplification of the transforming gene in
primary transformants (see below). Despite their higher
activity in the nude mouse assay, DNAs from primary
tumors still cannot induce foci of morphologically altered
NIH3T3 cells. This reflects, we think, an intrinsic difference
between the present assay and the focus assay.
DNAs from primary and secondary tumors were prepared
and analyzed by Southern blotting for the presence ofhuman
repetitive sequences (Fig. 1). This powerful method allows
the comparison of our putative transforming genes before
their actual isolation (27, 31). All secondary tumors derived
from the same primary tumor DNA contained a common set
of human repetitive sequences. However, these sets differed
among secondary tumors derived from different primary
tumor DNAs. From this observation we conclude that the
nude mouse assay appears to detect three different trans-
forming genes in the DNA of MCF-7 which we called mcfl,
mcf2, and mcf3. This conclusion was confirmed by subse-
quent experiments, described below.
Relation of mcf genes to the known ras genes. DNAs from
the three primary tumors were analyzed for the presence of
the three human ras genes, N-, H-, and K-ras, by Southern
analysis. Neither MCF-7-2 nor MCF-7-3 contained these
genes. Later studies showed that indeed the mcf2 and mcf3
genes are not even weakly related to members of the ras
gene family (see below).
DNA from MCF-7-1, however, contained 30 to 100 copies
of the human N-ras gene (Fig. 2). Moreover, all secondary
tumors derived from MCF-7-1 DNA contained a similar
number of copies of the human N-ras gene. Therefore, mcfl
was N-ras. Although EcoRI fragments with homology to N-
ras are seen in the MCF-7-1 secondary DNAs, they are not
the expected size. We cloned the N-ras gene from one of
these DNAs (MCF-7-1-1) and analyzed its structure. It
contained the 9.2-kbp fragment, which corresponds to the
intact 5' end of the N-ras gene (50), but had undergone
rearrangement in sequences which flanked the 3' end of the
gene. We next examined the possibility that the N-ras gene
of MCF-7 was itself rearranged. We performed Southern
blot analysis of MCF-7 DNA with an N-ras probe and
observed that this gene was not rearranged, at least within
the 16.3-kbp region containing a functional N-ras gene. This
was definitely established by the cloning of the N-ras region
from MCF-7 DNA. We conclude that rearrangement of the
TABLE 3. Lineages of tumors grown in nude mice'
Tumor Induced bydesignaTuon DNAdesignation from:
MCF-7-1 ..........................................
MCF-7-1-1.........................................
MCF-7-1-2.........................................
MCF-7-1-3 .........................................
MCF-7-2 ..........................................
MCF-7-2-1.........................................
MCF-7-2-2.........................................
MCF-7
MCF-7-1
MCF-7-1
MCF-7-1
MCF-7
MCF-7-2
MCF-7-2
MCF-7-3..... MCF-7
MCF-7-3-1..... MCF-7-3
MCF-7-3-2..... MCF-7-3
MCF-7-3-4..... MCF-7-3
a The tumors to which we refer by name in the text are listed, together with
the cell or tumor DNA which was used to induce them.
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FIG. 1. Human repeat sequences in transformants. DNAs (10 ,ug each) from the indicated tumors were digested with EcoRI and analyzed
by Southern hybridization for the presence of human repeat sequences under conditions of high stringency. Total nick-translated human DNA
was used as a probe. Numbers on the left are molecular weight markers in kilobases. Arrows indicate restriction endonuclease fragments with
human repeat sequences which have been consistently transferred into secondary transformants.
N-ras gene in NIH3T3 transformants therefore occurred
during or after gene transfer. Such rearrangements are
common events during gene transfer (14, 30).
These same studies, however, did indicate that the N-ras
gene of MCF-7 is present at several times the copy number
found in normal human diploid cells (Fig. 2). These blot
hybridization experiments were repeated several times with
the same results. We carefully monitored the amount of
DNA loaded per slot by ethidium bromide staining and UV
illumination of the agarose gel before DNA transfer onto
nitrocellulose. After hybridizing nitrocellulose filters with
nick-translated N-ras probes and performing an autoradio-
graphic exposure, we monitored the amount of DNA trans-
ferred from gels by rehybridizing these filters with nick-
A
a b c d e
-23.0
-4 9.5
- 6.8
- 2.3
i2
B
a b c d e FIG. 2. Presence of N-ras in transformants and MCF-7. Various
DNAs (10 F±g each) were digested with EcoRI and analyzed by
-23.0 Southern hybridization for the presence of the N-ras gene. The
partial cDNA clone p6aI (50) was nick translated and used as a
probe. This probe hybridizes more strongly with the 3' EcoRI
-
9.5 fragment of N-ras than with the 5' EcoRI fragment (50). (A) Lane a,
6.8
NIH3T3 DNA; lane b, DNA from a normal human fibroblast cell
- line, GM2998; lane c, DNA from a human placenta; lane d, DNA
from MCF-7 cells; lane e, DNA from the primary tumor MCF-7-1.
Nitrocellulose filters were exposed for 24 h at -70°C with intensify-
ing screens. (B) Lane a, DNA from primary tumor MCF-7-2; lane b,
4.3 DNA from primary tumor MCF-7-3; lane c, DNA from primary
tumor MCF-7-1; lane d, DNA from secondary tumor MCF-7-1-2;
lane e, DNA from secondary tumor MCF-7-1-3. The hybridizations
were done at high stringency. Exposure was for 12 h. Numbers on
the right are DNA molecular weight markers in kilobases.
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DETECTION OF HUMAN ONCOGENES 1699
translated total human DNA and performing a second
autoradiographic exposure. These studies indicated that N-
ras was present in MCF-7 cells at 5 to 10 times the levels
seen in cultured diploid human fibroblasts and human pla-
cental cells.
Induction of tumors with ras genes encoding normal pro-
teins. We were surprised to find that DNA from MCF-7-1
could not induce morphologically altered foci in NIH3T3
cells. When the N-ras gene was cloned from a tumor induced
by MCF-7-1 DNA, it too was unable to induce foci in
NIH3T3 cells. Since the focus assay is sensitive to activated
ras genes containing structural mutations, we tentatively
concluded that the N-ras gene of MCF-7 encodes a normal
protein product and, further, that the tumorigenicity assay,
unlike the focus assay, is sensitive to cellular genes with the
potential to induce tumorigenicity by increased expression
of unaltered protein products.
We directly tested this hypothesis by assaying an activat-
ed H-ras gene cloned from T24 bladder carcinoma cells (51),
a wild-type H-ras gene cloned from human placental cells
(51), an activated N-ras gene cloned from SK-N-SH cells
(50), and a wild-type N-ras gene cloned from human placen-
tal cells (50) (Table 3). The results are summarized in Table
4. The structurally mutated, transforming H-ras and N-ras
genes efficiently induced tumors. The H-ras and N-ras genes
cloned from human placental DNA were much less active
but did nevertheless efficiently induce tumors in nude mice.
We attribute this to the presence of multiple copies of these
genes in NIH3T3 cells after DNA transfer, a hypothesis
consistent with the work of others (5), who have shown that
cells expressing high levels of the human H-ras gene product
are tumorigenic.
It was still possible that the N-ras gene of MCF-7 con-
tained mutations which made it more active in the tumorige-
TABLE 4. Tumorigenicity assays of normal and mutant ras genes"
Mean tumor diam (mm) on day:
Donor DNA (ng) Group 7 14 21 28 35 43 50
NIH3T3 Al 0 0 0 0 0 0 0
A2 0
A3 0
0
0
0
0
0
0
0
0
0
0
0
0
NIH3T3 + H-ras-pT24 (10)
NIH3T3 + H-ras-pP3 (10)
Bi 7.8 21.5
B2 7.3 18.7
B3 8.4 22.8
Cl 0
C2 0
C3 0
0
0
0
0
0
0
4.9 12.4
0 0
4.5 11.4
NIH3T3 + H-ras-pP3 (100)
NIH3T3 + N-ras-ANS-35 (10)
NIH3T3 + N-ras-ANP-12 (10)
NIH3T3 + N-ras-XNP-12 (100)
Dl 0
D2 0
D3 0
4.2 13.2
4.9 14.3
5.3 8.9
17.7
20.8
16.5
El 7.3 27.3
E2 5.6 23.2
E3 6.8 20.8
E4 6.5 22.8
Fl 0
F2 0
F3 0
F4 0
G1 0
G2 0
G3 0
G4 0
0
0
0
0
0
0
0
0
0
0
0
0
0 0
Tr 5.1
6.2 10.2
0 0
0 9.6
5.7 11.6
5.8 11.2
3.9 8.9
NIH3T3 + N-ras-XMN-317 (10)
NIH3T3 + N-ras-XMN-317 (100)
Hl 0
H2 0
H3 0
H4 0
Ji 0
J2 0
J3 0
J4 0
0 0
0 0
0. 0.
0 0
0
0
0
0
0
0
0
0
0
0
0.
0
0 0 0
0 0 0
0. 4.0 8.4
0 7.9 18.1
8.4 16.5
7.6 12.5
Tr 7.2
8.4 15.3
24.6
20.8
15.8
20.5
K 10.4
19.5
8.4
18.8
20.8
16.5
19.5
0
12.0
15.8
0
8.4
15.3
20.3
0
15.3
20.7
20.0
15.6
al-1 18.7
a In this experiment, each plate of NIH3T3 cells was exposed to the usual concentration of pKOneo and 30 pLg of NIH3T3 DNA (groups A through J) or al-1
DNA (group K). Moreover, each plate (groups B through J) received the following additions: group B, 10 ng of the transforming human H-ras gene cloned from
T24 DNA, called plasmid pT24; groups C and D, 10 and 100 ng, respectively, of the wild-type H-ras gene cloned from human placental DNA, called plasmid pP3;
group E, 10 ng of the transforming human N-ras gene cloned from SK-N-SH neuroblastoma cells, called XNS-35; groups F and G, 10 and 100 ng, respectively, of
the wild-type N-ras gene cloned from human placental DNA, called XNP-12; groups H and J, 10 and 100 ng, respectively, of the human N-ras gene cloned from
MCF-7-1-1, called XMN-317.
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FIG. 3. EcoRI restriction fragments of clones of mcJ2 and mcf3. (A and C) EcoRI Inserts of independent X charon 4a clones of mef2 and
mcfl, respectively. Numbers to the left refer to the X clone designation (for example, clone X mcJ2-10 or X mcJ3-30B, etc.). (B and D)
Composite EcoRI restriction endonuclease map of these genes. Vertical lines indicate EcoRI sites. The relative position of the EcoRl
fragments was determined from digests of phages with overlapping inserts. Not all such phages are shown. Ambiguities in relative position are
indicated by arrows. Numbers below the fragments are their length in kbp. For each fragment, boxes indicate hybridization signal with total
human DNA (lower box), human alu clone blur 8 (20) (middle box), or total mouse DNA (upper box). Solid boxes indicate a strong
hybridization signal, slashed boxes indicate a very weak signal, and empty boxes indicate no observable hybridization signal. See Fig. 4 for
typical blot hybridization data.
nicity assay but not in the focus assay. However, the N-ras
gene cloned from MCF-7-1-1 was no more efficient at
inducing tumorigenicity than the N-ras gene cloned from
human placental DNA (Table 4). A similar result was
obtained when we assayed the N-ras gene cloned directly
from MCF-7 DNA (data not shown). These results suggest
that the N-ras gene of MCF-7 does not contain significant
structural mutations.
Preliminary characterization of the mcf2 and mcf3 genes.
We have cloned portions of the two other genes detected by
our assay of MCF-7 DNA. We used human repetitive
sequences to isolate these genes from A phage libraries we
constructed using DNA from secondary tumors MCF-7-2-2
and MCF-7-3-4. In retrospect, this isolation was greatly
facilitated by the high copy number of these genes present in
induced mouse tumors (see Fig. 5). From overlapping A
phage inserts we determined preliminary EcoRI maps of
these genes (Fig. 3). We also determined the presence of
mouse or human repeat sequences on these genes (Fig. 3 and
4). None of our clones have shown strong hybridization to
total nick-translated mouse DNA (Fig. 4D), but we observed
weak hybridization between some fragments and mouse
DNA upon long autoradiographic exposures (Fig. 4C). We
attribute this to weak homology between human and mouse
sequences since sequences which were cloned directly from
the human cell line MCF-7 also showed this weak hybridiza-
tion (Fig. 4, lane h). We present this data to facilitate the
subsequent unambiguous identification of new oncogenes as
they become isolated by others. However, we caution that
the human DNA which we have isolated may contain
rearrangements. Since none of our phage clones is biologi-
cally active in the nude mouse assay, these genes may be too
large to clone in a biologically active form as a A phage
insert, and we are currently isolating cosmid clones.
By blotting our cloned DNAs with total human or mouse
DNA, we identified relatively repeat-free restriction endonu-
clease fragments useful for Southern hybridization to geno-
mic DNAs. We then were able to examine the copy number
of these genes in our various transformants, in MCF-7 cells
themselves, and in transformed NIH3T3 cells obtained from
G. Cooper which he obtained by using MCF-7 DNA in a
focus assay (Fig. 5). Evidently, the mcf2 and mcf3 genes are
not related to each other. They are present in high copy
numbers in the primary tumors MCF-7-2 and MCF-7-3,
respectively, and in the respective secondary tumors derived
from them. However, neither gene appears to be amplified in
MCF-7 DNA itself. Significantly, neither gene appears to be
related to the gene that Lane et al. (25) reported to transfer
from MCF-7 DNA to NIH3T3 cells using an NIH3T3 focus
assay (Fig. 5, lanes h and i).
We finally used our cloned DNA as probes to search for
homology to known oncogenes. This was done by low-
stringency blot hybridization to complete or nearly complete
oncogene clones. For probes, we nick translated a total of
39.7 and 28.3 kbp from mcf2 and mcf3, respectively. No
homology was seen to the clones of oncogenes shown in
Table 5 (blot data not shown). Since this survey includes
most of the known cellular oncogenes, we conclude that
mcf2 and mcf3 are previously uncharacterized transforming
genes. This conclusion must be taken with caution, since we
do not know if the cloned portions of the mcf genes include
coding sequences.
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FIG. 4. Hybridization of phage clones of the mcJ2 and mcJ3 genes with human and mouse repetitive sequences. (A) Ethidium bromide
staining pattern of a 1% agarose gel loaded with 1.5 ,ug of EcoRI digests of DNA from the following A clones: X mcJ2-10,
-28, and -60 (lanes a, b, and c, respectively) from the secondary tumor MCF-7-2-2; X mcJ3-12A, -29, and -30B (lanes d, e, and f, respectively)
from the secondary tumor MCF-7-3-4; A mcj3-7A (lane h) from the human cell line MCF-7, which was isolated with an mcf3-specific probe.
Lane g shows an EcoRI-BamHI digest of K myc4.1.1, a cloned myc gene from mouse plasmacytoma MOPC315 (39) used as a positive control
for mouse repeat sequences. The length of the inserts, indicated except for lane g, is given in kbp. (B, C, and D) Southern blot hybridization of
the gel shown in (A) with nick-translated total human DNA after 2 h of exposure (B) and with nick-translated total mouse DNA after either 4
days (C) or 2 h (D) of exposure. The hybridizations were done at high stringency (see the text), and exposure was at -70°C with an
intensifying screen.
DISCUSSION
The decision to use tumorigenicity in nude mice rather
than focus formation to assay transforming genes was based
on two considerations. First, it was clearly at least theoreti-
cally possible for altered NIH3T3 cells to be tumorigenic yet
unable to form a recognizable focus of morphologically
altered cells under conditions of in vitro cultivation. Second,
morphologically altered foci of a certain type are sometimes
induced in cultures of NIH3T3 in response to the mere
physical presence of calcium phosphate-precipitated DNA
(31). This background of spontaneous foci potentially ob-
scured detection of certain transforming genes. A similar
approach to detecting transforming genes has been described
by Blair and co-workers (2), who injected NIH3T3 cells into
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FIG. 5. Presence of mcJ2 and mcJ3 genes in human DNA and DNA from transformants. DNAs (10 ,ug each) from various sources were
cleaved with EcoRI and analyzed by the method of Southern (45) for DNA sequences homologous to mcJ3 (A) or mcJ2 (B). Hybridization
probes used were: the 1.9-kbp alu-free EcoRI fragment of mc]3 and the 2.4-kbp alu-free fragment of mc]2, respectively (Fig. 3). DNAs were as
follows. (A) Lane a, NIH3T3 DNA; lane b, DNA from human fibroblast cells (GM2998); lane c, DNA from human placental cells; lane d,
DNA from MCF-7; lane e, DNA from primary tumor MCF-7-1; lane f, DNA from primary tumor MCF-7-2; lane g, DNA from primary tumor
MCF-7-3; lane h, DNA from Hul, a primary NIH3T3 focus transformant obtained from G. Cooper which reportedly contains a transforming
gene from MCF-7; lane i, DNA from Hu2, a second, but independent, NIH3T3 focus transformant of the same derivation as Hul; lanej, DNA
from the secondary tumor MCF-7-3-1; lane k, DNA from the secondary tumor MCF-7-3-2. In this experiment, the amount of MCF-7 DNA
loaded was proportionately less than the other lanes, as judged by ethidium bromide staining. (B) Lanes a through i were as in (A); lanes j and
k were DNAs from secondary tumors MCF-7-2-1 and MCF-7-2-2, respectively. The hybridizations were done at high stringency. Exposure
times were for 24 h with intensifying screens. Numbers on right are DNA size markers in kbp.
nude mice directly after exposure to tumor DNA. Our
method differs from theirs in the use of cotransfection.
The decision to utilize cotransfection, with selection for
G418 resistance, was based on the following considerations.
First, selection for a biochemical marker preselects for cells
competent in the uptake of DNA (54) and effectively re-
moves from the population spontaneously transformed
NIH3T3 cells which have not incorporated DNA. Second,
from previous studies we know that cells which incorporate
a selectable marker are likely to have incorporated, on
average, 3 x 103 kbp from the coprecipitated DNA (32). A
total of 103 G418-resistant colonies would likely have incor-
porated in total, therefore, about 3 x 106 kbp of coprecipitat-
ed DNA, or about one genomic equivalent. Third, by
allowing each G418-resistant colony to grow to a size of 104
cells, we could in principle detect tumor formation even
from weakly tumorigenic cell populations.
Using cotransfer and tumorigenicity in nude mice, we can
detect the transfer of three different genes from MCF-7 DNA
into NIH3T3 cells which we cannot detect using the focus
assay with this DNA as donor. One of the genes which we
have transferred from MCF-7 DNA is N-ras. To determine if
there are mutations associated with the N-ras gene, we
cloned this gene from both MCF-7 and the secondary tumor
MCF-7-1-1. These N-ras genes are no more potent in the
tumorigenicity assay than an N-ras gene cloned from human
placental cells. Although this does not rule out alterations
associated with this gene outside of the cloned region, it
suggests that there are no significant structural mutations
within coding regions. Since the N-ras gene is highly ampli-
fied in MCF-7-1-1 and since DNA from MCF-7-1-1 has a high
transforming potential in the nude mouse assay, we conclude
that the tumorigenicity assay may serve to identify tumor
DNAs containing highly amplified genes with transforming
potential, even when those genes do not contain structural
gene mutations. The tumorigenicity assay differs from the
focus assay in this respect, and in fact we have shown that,
in a dose-dependent manner, DNAs containing high copy
numbers of normal ras genes do induce tumorigenicity.
Our blot hybridization data indicate that the N-ras gene is
amplified in MCF-7 cells. In a survey of 10 other human
tumors and tumor cell lines (42; unpublished studies) we
have not previously observed amplification of the N-ras
gene. MCF-7 cells thus have a genetic abnormality associat-
ed with N-ras. Amplification of other ras genes, however,
has been observed in some tumors and tumor cell lines (14,
37; our unpublished studies).
Two of the genes we have transferred from MCF-7, mcf2
and mcf3, appear to be unrelated to any of the previously
identified oncogenes which we have examined. Moreover,
an oncogene in MCF-7 cells, detectable after transfer by the
NIH3T3 focus assay, was previously reported by Cooper
and co-workers (25). Neither the mcJ2 nor the mcf3 gene
appears to be related to the gene reported by those workers.
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TABLE 5. Molecular clones of oncogenes
Gene Origin Plasmid Referencedesignation
abl Abelson murine leukemia virus pAB-sub3 13
erb Avian erythroblastosis virus pAE-PulII 52
fes GA feline sarcoma virus pGA-FeSV 12
fos FBJ osteosarcoma virus pFBJ-2 7
fmis SM feline sarcoma virus pSM-FeSV 9
fps PRCII avian sarcoma virus pRCII-1B Hanafusa'
H-ras Harvey murine sarcoma virus pHB-11 10
int-I Mouse mammary carcinoma pMT-2.5 28
K-ras Kirsten murine sarcoma virus pKBE-2 10
mos Moloney murine sarcoma virus pm-1 3
myb Avian myeloblastosis virus pVM-2 23
myc Avian myelocytomatosis pMCV38 53
N-ras Human neuroblastoma p6al 50
rel Reticuloendotheliosis virus pRev-T3 6
ros UR2 avian sarcoma virus pBR-UR2 Hanafusa"
sis Simian sarcoma virus pSSV-l1 35
ski Avian SKV770 virus pvski-1 Stavnezer"
src Rous sarcoma virus psrc-11 38
yes Y73 sarcoma virus pBR-Y73 22
a Personal communications. Avian SKV770 virus is described in reference 47.
A more definitive conclusion, however, must await the
identification of mc]2 and mcJ3 coding regions.
We do not know if the mcJ2 and mcJ3 genes of MCF-7 cells
have genetic abnormalities. On the one hand, it would not be
particularly surprising to find multiple weakly transforming
genetic lesions in MCF-7 cells or, for that matter, most
tumorigenic cells. On the other hand, neither would it be
surprising if either or both mcf2 and mcJ3 are indeed normal
genes which can induce tumorigenicity by overexpression
after gene transfer into NIH3T3 cells. To answer these
questions, it will be necessary to clone these genes in a
biologically active form both from MCF-7 and from normal
human DNA to compare their transforming activities.
In summary, we have described a tumorigenicity assay for
transforming genes which differs considerably from the
NIH3T3 focus assay. We do not fully understand the basis of
this difference, nor do we know if the genes we detect with
the assay will usually reflect genetic abnormalities in the
DNA being tested. Indeed, our results strongly suggest that,
with some frequency, normal genes with transforming poten-
tial will sometimes be detected. Nevertheless, we appear to
have uncovered a previously unknown genetic abnormality
in MCF-7 cells and have probably discovered two previously
unknown human oncogenes.
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